Guiding ATMPs to patients

Here you will find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and effective patient solutions.

Register for ATMP Sweden 2020 in Stockholm!

Register for Sweden's premier annual ATMP conference!

Join us in Stockholm April 1-3, 2020. Sponsorship package now available! Find our more here!

Read more

Subscribe to our mailing list

Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.

Follow us on LinkedIn!


Check out the ATMP map

Use our interactive map to find clinics, manufacture facilities and CAMP/Swelife-ATMP partners.

The ATMP regulatory guide

Use this guide to navigate development of your ATMP to Phase I!

What are ATMPs?

What is the difference between a transplant and a cell based ATMP?


Cognate Bioservices aquires Cobra Biologics


Creates global cell and gene therapy manufacturing services platform

Read more

Gene therapy reduces Acute Intermittent Porphyria attacks by 79%


Promising results from Swedish study published in The New England Journal of Medicine

Read more

Register before November 15th for ATMP PhD courses!


Two great courses covering some ATMP science and the field as a whole

Read more
Display all news




Open meeting: Business models and health economics





Pre-GMP facility inauguration workshop!





Advanced bioreactor cultivation technology


Show all events

Work with us!

CAMP partners

Join our experts in the science and technology for GMP compliant clinical translation of ATMPs.

Swelife-ATMP partners

Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.

We want to hear about your activities!

Help us to help you get information out about your ATMP press releases or events in Sweden!

ATMP success stories

From 'bubble babies' to cancer - How ATMPs are revolutionising medicine

There are cell and gene therapies being developed all over the world for a variety of indications. Find our more about ATMP successes here!

Read more

Other collaborating national projects

VOG Cell

VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.


AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.

Future Medicine

This Group will be developing a long term strategy for the future of the ATMP field in Sweden. The Project will ensure that all necessary networks and stakeholders are involved.

See all ATMP relevant organisations here